$VCYT
Veracyte Inc

2021 Q2 Form 10-Q Financial Statement

#000138410121000139 Filed on July 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $55.11M $20.70M $31.12M
YoY Change 166.16% -31.3% 5.39%
Cost Of Revenue $17.47M $7.660M $12.24M
YoY Change 128.09% -12.73% 43.78%
Gross Profit $37.63M $13.05M $18.88M
YoY Change 188.38% -38.9% -10.16%
Gross Profit Margin 68.29% 63.03% 60.66%
Selling, General & Admin $35.14M $18.66M $25.40M
YoY Change 88.31% -10.57% 31.04%
% of Gross Profit 93.36% 142.97% 134.52%
Research & Development $6.249M $4.169M $4.407M
YoY Change 49.89% 25.2% 28.3%
% of Gross Profit 16.61% 31.95% 23.34%
Depreciation & Amortization $4.500M $1.960M $1.972M
YoY Change 129.59% 113.04% 108.68%
% of Gross Profit 11.96% 15.02% 10.44%
Operating Expenses $41.38M $22.83M $29.80M
YoY Change 81.29% -5.65% 30.63%
Operating Profit -$7.474M -$11.05M -$12.20M
YoY Change -32.37% 256.48% 490.23%
Interest Expense $63.00K $65.00K $55.00K
YoY Change -3.08% -72.34% -81.85%
% of Operating Profit
Other Income/Expense, Net -$1.716M $91.00K $539.0K
YoY Change -1985.71% -89.18% 18.98%
Pretax Income -$9.190M -$11.03M -$11.72M
YoY Change -16.64% 342.77% 510.21%
Income Tax -$200.0K $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.038M -$11.03M -$11.72M
YoY Change -18.02% 342.06% 511.16%
Net Earnings / Revenue -16.4% -53.25% -37.65%
Basic Earnings Per Share -$0.13 -$0.22
Diluted Earnings Per Share -$0.13 -$0.22 -$235.4K
COMMON SHARES
Basic Shares Outstanding 67.32M shares 50.21M shares 49.74M shares
Diluted Shares Outstanding 67.32M shares 50.21M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $327.5M $147.5M $153.1M
YoY Change 122.06% -23.42% 125.81%
Cash & Equivalents $327.5M $147.5M $153.1M
Short-Term Investments
Other Short-Term Assets $5.263M $2.900M $3.000M
YoY Change 81.48% 11.54% 25.0%
Inventory $6.674M $7.041M $6.094M
Prepaid Expenses
Receivables $31.86M $15.31M $19.09M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $371.3M $172.7M $181.4M
YoY Change 115.04% -21.49% 100.14%
LONG-TERM ASSETS
Property, Plant & Equipment $11.81M $8.640M $8.788M
YoY Change 36.72% 6.01% 8.31%
Goodwill $471.8M $2.725M $2.725M
YoY Change 17212.44% 157.81% 157.81%
Intangibles $155.7M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.504M $1.271M $1.302M
YoY Change 18.33% 19.79% 24.12%
Total Long-Term Assets $656.1M $84.05M $85.74M
YoY Change 680.6% 159.19% 160.44%
TOTAL ASSETS
Total Short-Term Assets $371.3M $172.7M $181.4M
Total Long-Term Assets $656.1M $84.05M $85.74M
Total Assets $1.027B $256.7M $267.1M
YoY Change 300.19% 1.73% 116.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.472M $2.224M $7.665M
YoY Change 280.94% -45.24% 88.61%
Accrued Expenses $20.76M $9.386M $10.08M
YoY Change 121.14% -4.42% 14.69%
Deferred Revenue $566.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $36.11M $13.11M $19.19M
YoY Change 175.51% -14.46% 33.95%
LONG-TERM LIABILITIES
Long-Term Debt $917.0K $801.0K $748.0K
YoY Change 14.48% 36.92% -94.18%
Other Long-Term Liabilities $18.46M $16.70M $16.70M
YoY Change 10.56% 36.89% 32.54%
Total Long-Term Liabilities $917.0K $801.0K $748.0K
YoY Change 14.48% 36.92% -94.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.11M $13.11M $19.19M
Total Long-Term Liabilities $917.0K $801.0K $748.0K
Total Liabilities $56.26M $30.59M $36.68M
YoY Change 83.91% 8.72% -7.76%
SHAREHOLDERS EQUITY
Retained Earnings -$332.5M -$269.4M -$258.4M
YoY Change 23.41% 12.97% 9.49%
Common Stock $1.304B $495.6M $488.8M
YoY Change 163.06% 7.1% 52.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $971.2M $226.1M $230.4M
YoY Change
Total Liabilities & Shareholders Equity $1.027B $256.7M $267.1M
YoY Change 300.19% 1.73% 116.21%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$9.038M -$11.03M -$11.72M
YoY Change -18.02% 342.06% 511.16%
Depreciation, Depletion And Amortization $4.500M $1.960M $1.972M
YoY Change 129.59% 113.04% 108.68%
Cash From Operating Activities $1.886M -$8.420M -$5.301M
YoY Change -122.4% 242.28% 424.33%
INVESTING ACTIVITIES
Capital Expenditures -$1.523M -$640.0K $665.0K
YoY Change 137.97% -1.54% -13.07%
Acquisitions $0.00
YoY Change
Other Investing Activities $2.999M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $1.476M -$640.0K -$665.0K
YoY Change -330.62% -3.03% -11.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities 1.922M 3.390M -$219.0K
YoY Change -43.3% -97.35% -97.39%
NET CHANGE
Cash From Operating Activities 1.886M -8.420M -$5.301M
Cash From Investing Activities 1.476M -640.0K -$665.0K
Cash From Financing Activities 1.922M 3.390M -$219.0K
Net Change In Cash 5.284M -5.670M -$6.185M
YoY Change -193.19% -104.54% -39.09%
FREE CASH FLOW
Cash From Operating Activities $1.886M -$8.420M -$5.301M
Capital Expenditures -$1.523M -$640.0K $665.0K
Free Cash Flow $3.409M -$7.780M -$5.966M
YoY Change -143.82% 329.83% 235.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001384101
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36156
dei Entity Registrant Name
EntityRegistrantName
VERACYTE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5455398
dei Entity Address Address Line1
EntityAddressAddressLine1
6000 Shoreline Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
243-6300
dei Security12b Title
Security12bTitle
Common Stock, par value, $0.001 per share
dei Trading Symbol
TradingSymbol
VCYT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67473870 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327545000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349364000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8990000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31864000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18461000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
6674000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
4657000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5263000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3197000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
371346000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
375679000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11813000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14559000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7843000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
155700000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59924000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
471764000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2725000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1504000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1399000 USD
CY2021Q2 us-gaap Assets
Assets
1027435000 USD
CY2020Q4 us-gaap Assets
Assets
457163000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8472000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3116000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20756000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11705000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
566000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
371000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3375000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2936000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1589000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
36105000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16781000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
917000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
810000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
662000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
829000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
773000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4467000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7594000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13334000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9917000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
56258000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
35931000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67471551 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67471551 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58200526 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58200526 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
67000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
58000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1303610000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
702768000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-332500000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-281594000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
971177000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
421232000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1027435000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
457163000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55105000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20704000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91808000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51826000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6249000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4169000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11585000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8576000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19662000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10701000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35958000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28285000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15473000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7957000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61755000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15770000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3723000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1273000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5524000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2548000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
62579000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
31755000 USD
us-gaap Costs And Expenses
CostsAndExpenses
144697000 USD
us-gaap Costs And Expenses
CostsAndExpenses
75077000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7474000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11051000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-52889000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23251000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
63000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
65000 USD
us-gaap Interest Expense
InterestExpense
116000 USD
us-gaap Interest Expense
InterestExpense
120000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1653000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
91000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1848000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
630000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9190000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11025000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-54853000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22741000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-152000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3947000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9038000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-9038000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11025000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11025000 USD
us-gaap Net Income Loss
NetIncomeLoss
-50906000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50906000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22741000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22741000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67316065 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67316065 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50212123 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50212123 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65334890 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65334890 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50002377 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50002377 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
974231000 USD
CY2021Q2 vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
2630000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
710000 USD
CY2021Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
3671000 USD
CY2021Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
14000 USD
CY2021Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
379000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9038000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-9038000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
971177000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
421232000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38677000 USD
vcyt Stock Issued And Sold During Period Value In Private Placement
StockIssuedAndSoldDuringPeriodValueInPrivatePlacement
593821000 USD
vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
5436000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1159000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7484000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
7328000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
30000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
561000 USD
us-gaap Net Income Loss
NetIncomeLoss
-50906000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50906000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
971177000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
230422000 USD
CY2020Q2 vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
3764000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
374000 USD
CY2020Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
3009000 USD
CY2020Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
20000 USD
CY2020Q2 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
331000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11025000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11025000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
226147000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239455000 USD
vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
4745000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1101000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2678000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
5560000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
20000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
685000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22741000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22741000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
226147000 USD
us-gaap Net Income Loss
NetIncomeLoss
-50906000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22741000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7050000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3929000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7919000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6265000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3947000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
vcyt Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty
DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty
107000 USD
vcyt Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty
DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty
107000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
1088000 USD
vcyt Noncash Lease Expense
NoncashLeaseExpense
885000 USD
vcyt Noncash Lease Expense
NoncashLeaseExpense
469000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
247000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-140000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1866000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6713000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4023000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
375000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1323000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1288000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
664000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
30000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-166000 USD
vcyt Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1017000 USD
vcyt Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-682000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1314000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2758000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
122000 USD
vcyt Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
4770000 USD
vcyt Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
-4343000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38674000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13724000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
574411000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
3000000 USD
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2723000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1314000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-574134000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
593821000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7484000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2678000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6595000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5849000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
592932000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3171000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19876000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11867000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1797000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21673000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11867000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
349967000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159920000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328294000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148053000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1019000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Interest Paid Net
InterestPaidNet
9000 USD
us-gaap Interest Paid Net
InterestPaidNet
3000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327545000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349364000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328294000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
349967000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Items subject to such estimates include: revenue recognition; write-down of supplies; the useful lives of property and equipment; the recoverability of long-lived assets; the incremental borrowing rate for leases; accounting for acquisitions; the estimation of the fair value of intangible assets and contingent consideration; variable interest entity assessment; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; reserve on accounts receivable and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</span></div>
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8547297 shares
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
593800000 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
38700000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4760414 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5795658 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4803895 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5756805 shares
CY2020Q4 us-gaap Goodwill
Goodwill
2725000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
469039000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
471764000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
164420000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16020000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
148400000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
70420000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10496000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
59924000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y8M12D
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
7300000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
7300000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
171720000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16020000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
155700000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
70420000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10496000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59924000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3700000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7448000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
14894000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14894000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14854000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14408000 USD
CY2021Q2 vcyt Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
81902000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
148400000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12600000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9201000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8156000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2504000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20756000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11705000 USD
CY2021Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3500000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1841000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3770000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3880000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3991000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4103000 USD
CY2021Q2 vcyt Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
1661000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19246000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2976000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
16270000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2936000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13334000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
902000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
472000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1477000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
944000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
919000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
586000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1507000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1157000 USD
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11104580 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9500287 shares
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD

Files In Submission

Name View Source Status
0001384101-21-000139-index-headers.html Edgar Link pending
0001384101-21-000139-index.html Edgar Link pending
0001384101-21-000139.txt Edgar Link pending
0001384101-21-000139-xbrl.zip Edgar Link pending
ex101-andersonexecutivecha.htm Edgar Link pending
ex102-stapleyceoemployment.htm Edgar Link pending
ex103-stapleyceocicseveran.htm Edgar Link pending
ex104-haliodxxmouspa.htm Edgar Link pending
ex105haliodxspa.htm Edgar Link pending
exhibit31106-30x2021.htm Edgar Link pending
exhibit31206-30x2021.htm Edgar Link pending
exhibit32106-30x2021.htm Edgar Link pending
exhibit32206-30x2021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logotm1a.jpg Edgar Link pending
logotma.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vcyt-20210630.htm Edgar Link pending
vcyt-20210630.xsd Edgar Link pending
vcyt-20210630_cal.xml Edgar Link unprocessable
vcyt-20210630_def.xml Edgar Link unprocessable
vcyt-20210630_htm.xml Edgar Link completed
vcyt-20210630_lab.xml Edgar Link unprocessable
vcyt-20210630_pre.xml Edgar Link unprocessable